Nasdaq surges 3% on growing optimism over potential Iran war resolution Wall Street rises as Iran conflict may ease; Nasdaq leads, yields fall, sectors shift. Learn more here.

Nasdaq surges 3% on growing optimism over potential Iran war resolution

#dji #sp500 #comp:ind #biib #mrvl #us10y #us2y #us30y

Origin | Interest | Match

Biogen to Acquire Apellis, Enhancing the Company’s Growth Portfolio in Immunology and Rare Disease, Bolstering Growth Outlook and Accelerating Expansion into Nephrology Biogen (Nasdaq: BIIB) agreed to acquire Apellis for $41.00 per share in cash (≈$5.6 billion) plus a contingent value right (CVR) tied to SYFOVRE® sales, with closing expected Q2 2026.The deal adds two commercial complement medicines with combined 2025 net sales of $689 million, projected to grow in the mid-to-high teens at least through 2028, and is expected to be accretive to non-GAAP EPS starting in 2027.

#BIIB Biogen to Acquire Apellis, Enhancing the Company’s Growth Portfolio in Immunology and Rare Disease, Bolstering Growth Outlook and Accelerating Expansion into Nephrology

www.stocktitan.net/news/BIIB/biogen-to-acqu...

FDA Approves New High Dose Regimen of SPINRAZA® (nusinersen) for Spinal Muscular Atrophy Biogen (Nasdaq: BIIB) announced FDA approval of a High Dose Regimen of SPINRAZA (nusinersen) for spinal muscular atrophy on March 30, 2026. The regimen uses 50 mg/5 mL loading doses and 28 mg/5 mL maintenance every four months and will be available in the United States in the coming weeks.The approval is based on the Phase 2/3 DEVOTE study showing a mean CHOP-INTEND improvement of 26.19 points versus a matched sham group (p<0.0001). High Dose SPINRAZA is also approved in the EU, Switzerland, and Japan.

#BIIB FDA Approves New High Dose Regimen of SPINRAZA® (nusinersen) for Spinal Muscular Atrophy

www.stocktitan.net/news/BIIB/fda-approves-n...

Results from Real-World, Long-Term Treatment Persistence with LEQEMBI® (lecanemab-irmb) in the United States Presented at AD/PD™ 2026 TOKYO and CAMBRIDGE, Mass., March 20, 2026/ PRNewswire/-- Eisai Co., Ltd. and Biogen Inc. announced today that new real‑ world findings from an analysis of long‑ term treatment persistence and baseline characteristics among people receiving intravenous lecanemab, an anti‑ amyloid‑ β protofibril antibody, showed that most patients continue with ongoing lecanemab...

#BIIB Results from Real-World, Long-Term Treatment Persistence with LEQEMBI® (lecanemab-irmb) in the United States Presented at AD/PD™ 2026

www.stocktitan.net/news/BIIB/results-from-r...

Dow drops as oil prices rise again, retail inflation comes as expected (SP500:) Stocks edge higher ahead of the CPI inflation report as traders weigh U.S.-Israel-Iran tensions, yields and top premarket movers—read now.

Dow drops as oil prices rise again, retail inflation comes as expected

#sp500 #dji #comp:ind #vrsn #orcl #biib #ptc #epam #fang #co1:com #cl1:com

Origin | Interest | Match

Biogen Presents Additional Salanersen Data Showing New Motor Milestones Achieved in Children with SMA Previously Treated with Gene Therapy Biogen (Nasdaq: BIIB) presented Phase 1b data showing salanersen, an investigational once-yearly antisense oligonucleotide for spinal muscular atrophy (SMA), was generally well tolerated and associated with functional improvement in 24 children previously treated with gene therapy.Key findings: sustained 75% reductions in neurofilament light chain at six months for participants with elevated baseline NfL, 12 of 24 achieved new WHO motor milestones, and all maintained or improved baseline milestones. Biogen also launched a global Phase 3 program (STELLAR-1, STELLAR-2, SOLAR) with planned initiations in Q2–Q3 2026.

#BIIB Biogen Presents Additional Salanersen Data Showing New Motor Milestones Achieved in Children with SMA Previously Treated with Gene Therapy

www.stocktitan.net/news/BIIB/biogen-present...

BIIB Regalos Originales para Hombre, Regalo Dia del Padre, Gadget Inusual Útil Guantes LED Luminosos, Dia del Padre Regalos, San Valentín Hombre, Regalo Cumpleaños Hombre Mujer, Regalo Papa : Amazon.e... BIIB Regalos Originales para Hombre, Regalo Dia del Padre, Gadget Inusual Útil Guantes LED Luminosos, Dia del Padre Regalos, San Valentín Hombre, Regalo Cumpleaños Hombre Mujer, Regalo Papa : Amazon.e...

[Publi] ⬇️ #Descuento del 60%
✅ Código: CMU9BTB6 + Aplicar cupón
⌛ Hasta el 8 de marzo
🧤 #GuantesLED Luminosos #BIIB
💸 Por sólo 5.59€
👆🏼 Link aquí: amzlink.to/az0jDbFiE6RuL
#Chollo #Oferta #Amazon

Biogen to Share New SMA Data at Muscular Dystrophy Association and SMA Europe Conferences Long-term data from DEVOTE/ONWARD studies show benefits of high dose nusinersen in people living with spinal muscular atrophy (SMA) New Phase 1b data further illustrate potential of salanersen in SMA, as Phase 3 studies begin to evaluate this investigational drug that has the potential for high

#BIIB Biogen to Share New SMA Data at Muscular Dystrophy Association and SMA Europe Conferences

www.stocktitan.net/news/BIIB/biogen-to-shar...

The New England Journal of Medicine Publishes First Data to Demonstrate the Potential for Disease Modification in Dravet Syndrome Biogen (NASDAQ: BIIB) and Stoke Therapeutics announced NEJM publication showing zorevunersen data suggesting potential disease modification in Dravet syndrome.Phase 1/2a and open‑label extensions reported substantial, durable seizure reductions and multi‑year cognitive, behavioral and quality‑of‑life improvements; 81 patients received drug and >800 doses administered; Phase 3 EMPEROR readout expected mid‑2027.

#BIIB The New England Journal of Medicine Publishes First Data to Demonstrate the Potential for Disease Modification in Dravet Syndrome

www.stocktitan.net/news/BIIB/the-new-englan...

Gilbert Cisneros - Integrity Index View Gilbert Cisneros's political integrity grade, campaign financing, and conflicts of interest.

Rep. Gilbert Cisneros (D) disclosed 22 trades:
Traded: Jan 30 | Disclosed: Feb 13

Bought: $HD ($1K-$15K), $AZO ($1K-$15K), $VRT ($1K-$15K), $ISRG ($1K-$15K), $PWR ($1K-$15K), $AMZN ($1K-$15K), $COIN ($1K-$15K), $BIIB ($1K-$15K) +13 more
Sold: $PG ($1K-$15K)

https://integrityindex.us/candidate/g

BIIB Regalos Originales para Hombre, Regalo Dia del Padre, Gadget Inusual Útil Guantes LED Luminosos, Dia del Padre Regalos, Regalo Hombre, Regalo Cumpleaños Hombre Mujer, Regalo Papa : Amazon.es: Bri... BIIB Regalos Originales para Hombre, Regalo Dia del Padre, Gadget Inusual Útil Guantes LED Luminosos, Dia del Padre Regalos, Regalo Hombre, Regalo Cumpleaños Hombre Mujer, Regalo Papa : Amazon.es: Bri...

[Publi] ⬇️ #Descuento del 50%
✅ Código: RC68A5FF
⌛ Hasta el 25 de enero
🧤 #Guantes LED Luminosos #BIIB
💸 Por sólo 6.99€
👆🏼 Link aquí: amzlink.to/az0N8lhFXCg9x
#Chollo #Oferta #Amazon

Biogen Receives European Commission Approval for High Dose Regimen of SPINRAZA® (nusinersen) for Spinal Muscular Atrophy Biogen (Nasdaq: BIIB) announced European Commission approval of a high dose regimen of SPINRAZA (nusinersen) for 5q spinal muscular atrophy on January 12, 2026. The regimen updates dosing to two 50 mg loading doses 14 days apart followed by 28 mg maintenance injections every four months, with a single 50 mg replacement for patients transitioning from 12 mg.Approval is supported by DEVOTE Phase 2/3 data showing a CHOP-INTEND mean difference of 26.19 points (treatment-naïve infants) and HFMSE mean improvement of 1.8 points in transitioned patients; safety was generally consistent with the 12 mg regimen.

#BIIB Biogen Receives European Commission Approval for High Dose Regimen of SPINRAZA® (nusinersen) for Spinal Muscular Atrophy

www.stocktitan.net/news/BIIB/biogen-receive...

The Journal of the American Medical Association (JAMA) Neurology Publishes Long Term Results from the QALSODY Phase 3 VALOR Study and its Open-Label Extension in SOD1-ALS Biogen (Nasdaq: BIIB) reported JAMA Neurology publication of final Phase 3 VALOR and open‑label extension results for QALSODY (tofersen) in SOD1‑ALS with >3.5 years follow‑up.Key findings: early initiation of QALSODY was associated with numerically slower decline in clinical function, breathing, and strength, plus a reduced risk of death or permanent ventilation. Sustained reductions in plasma neurofilament light chain (NfL) were observed, supporting impact on disease biology. QALSODY is approved in 44 countries and holds accelerated U.S. approval based on NfL reduction; continued U.S. approval may be contingent on confirmatory clinical benefit.

#BIIB The Journal of the American Medical Association (JAMA) Neurology Publishes Long Term Results from the QALSODY Phase 3 VALOR Study and its Open-Label Extension in SOD1-ALS

www.stocktitan.net/news/BIIB/the-journal-of...

Lululemon to exit Nasdaq 100 with Seagate among additions Lululemon Athletica (LULU) to exit the Nasdaq 100 as part of the gauge's annual shakeup, with Seagate (STX) and five others considered for additions. Read more here.

Lululemon, Biogen to exit Nasdaq 100 with Alnylam, Seagate among additions

#lulu #ttd #alny #qqq #stx #wdc #biib #mpwr #on #insm #cdw

Origin | Interest | Match

Stock index futures, yields tread water with Fed decision in view Stock index futures were mixed before the bell Wednesday as investors awaited the Federal Reserve’s decision this afternoon.

Stock index futures, yields tread water with Fed decision in view

#spx #indu #us100:ind #nrg #biib #hsic #rmd #cboe #btc-usd #xagusd:cur #xauusd:cur

Origin | Interest | Match

Biogen and Dayra Therapeutics Announce Research Collaboration to Discover and Develop Oral Macrocyclic Peptides for a Range of Immunological Conditions Biogen (Nasdaq: BIIB) and Dayra Therapeutics announced a research collaboration on November 24, 2025 to discover and develop oral macrocyclic peptides for priority immunological targets.Key terms include a $50 million upfront payment to Dayra, program-level option and milestone payments, and Biogen leading further development, manufacturing, and potential commercialization. Biogen will record the upfront as an Acquired In-Process R&D expense in Q4 2025, and the amount was included in Biogen’s updated 2025 guidance issued October 30, 2025.

#BIIB Biogen and Dayra Therapeutics Announce Research Collaboration to Discover and Develop Oral Macrocyclic Peptides for a Range of Immunological Conditions

www.stocktitan.net/news/BIIB/biogen-and-day...

Biogen to Highlight New Lecanemab Data and Scientific Advances at the 18th Clinical Trials on Alzheimer’s Disease Conference New lecanemab findings highlight the safety and potential benefits of subcutaneous administration for initiation dosing, the potential for additional long-term clinical benefits with continued treatment, and real-world experience Biogen is committed to deepening scientific understanding of

#BIIB Biogen to Highlight New Lecanemab Data and Scientific Advances at the 18th Clinical Trials on Alzheimer’s Disease Conference

www.stocktitan.net/news/BIIB/biogen-to-high...

BIIB Regalo Hombre, Regalos Originales para Hombre, Gadget Inusual Útil Guantes LED Luminosos, Regalo Hombre Cumpleaños Mujer, Regalos Hombre Navidad Gadgets Tecnologicos : Amazon.es: Bricolaje y herr... BIIB Regalo Hombre, Regalos Originales para Hombre, Gadget Inusual Útil Guantes LED Luminosos, Regalo Hombre Cumpleaños Mujer, Regalos Hombre Navidad Gadgets Tecnologicos : Amazon.es: Bricolaje y herr...

[Publi] ⬇️ #Descuento del 53%
✅ Código: YN56S7K6
⌛ Hasta el 19 de noviembre
🧤 #Guantes LED Luminosos #BIIB
💸 Por sólo 6.64€
👆🏼 Link aquí: amzlink.to/az00XE7DlzTrO
#Chollo #Oferta #Amazon

BIIB Regalos Originales para Hombre, Gadgets Tecnologicos, Regalo Hombre Navidad, Herramienta Magnetica con LED, Regalo Cumpleaños Hombre Mujer, Regalo Dia del Padre, Regalo San Valentin Hombre Mujer ... BIIB Regalos Originales para Hombre, Gadgets Tecnologicos, Regalo Hombre Navidad, Herramienta Magnetica con LED, Regalo Cumpleaños Hombre Mujer, Regalo Dia del Padre, Regalo San Valentin Hombre Mujer ...

[Publi] ⬇️ #Descuento del 55%
✅ Código: 59NY8E88
⌛ Hasta el 19 de noviembre
💡 Herramienta Magnetica con #LED #BIIB
💸 Por sólo 7.22€
👆🏼 Link aquí: amzlink.to/az001Yv1wDRap
#Chollo #Oferta #Amazon

Wearxi Regalo Navaja Multiusos para Hombre, Ideas Originales para Padre, San Valentín y Navidad, 13 en 1 Camping Accesorios, Cuchillo Supervivencia : Amazon.es: Bricolaje y herramientas Wearxi Regalo Navaja Multiusos para Hombre, Ideas Originales para Padre, San Valentín y Navidad, 13 en 1 Camping Accesorios, Cuchillo Supervivencia : Amazon.es: Bricolaje y herramientas

[Publi] ⬇️ #Descuento del 53%
✅ Código: XGNBCH3N
⌛ Hasta el 19 de noviembre
🔪 #Navaja Multiusos #BIIB
💸 Por sólo 9.94€
👆🏼 Link aquí: amzlink.to/az0fXMdFe31sb
#Chollo #Oferta #Amazon

BIIB Regalo Hombre, 12 en 1 Multiherramienta Camping Accesorios, Regalos Originales para Hombres, Regalo Hombres Cumpleaños, Regalos Navidad, Regalos Hombre Navidad Gadgets Tecnologicos : Amazon.es: B... BIIB Regalo Hombre, 12 en 1 Multiherramienta Camping Accesorios, Regalos Originales para Hombres, Regalo Hombres Cumpleaños, Regalos Navidad, Regalos Hombre Navidad Gadgets Tecnologicos : Amazon.es: B...

[Publi] ⬇️ #Descuento del 53%
✅ Código: 8VOW6TV4
⌛ Hasta el 18 de noviembre
⚒️ 12 en 1 #Multiherramienta Camping #BIIB
💸 Por sólo 9.49€
👆🏼 Link aquí: amzlink.to/az0XBJmQ0JiIL
#Chollo #Oferta #Amazon

High Dose Regimen of Nusinersen Receives Positive CHMP Opinion for the Treatment of Spinal Muscular Atrophy Positive CHMP opinion is based on data from the DEVOTE study which evaluated the high dose regimen of nusinersen in treatment-naive participants and those transitioning from the currently approved 12mg dose regimen 1 Final European Commission decision expected in January 2026 SMA is a rare,

#BIIB High Dose Regimen of Nusinersen Receives Positive CHMP Opinion for the Treatment of Spinal Muscular Atrophy

www.stocktitan.net/news/BIIB/high-dose-regi...

BIIB Regalo Hombre, Regalos Originales para Hombre, Gadget Inusual Útil Guantes LED Luminosos, Regalo Hombre Cumpleaños Mujer, Regalos Hombre Navidad Gadgets Tecnologicos : Amazon.es: Bricolaje y herr... BIIB Regalo Hombre, Regalos Originales para Hombre, Gadget Inusual Útil Guantes LED Luminosos, Regalo Hombre Cumpleaños Mujer, Regalos Hombre Navidad Gadgets Tecnologicos : Amazon.es: Bricolaje y herr...

[Publi] ⬇️ #Descuento del 60%
✅ Código: JND85CMN + Aplicar cupón
⌛ Hasta el 14 de noviembre
🧤 #GuantesLED Luminosos #BIIB
💸 Por sólo 5.59€
👆🏼 Link aquí: amzlink.to/az0ZY2HWXQrGZ
#Chollo #Oferta #Amazon

Exciting week ahead in earnings! Compare your forecasting skills against Estimize community! Check out our Earnings Calendar: ⏩ tinyurl.com/3ee55ke3 #AAPL, #AMZN, #BIIB, #BKNG, #CMG, #EBAY, #FFIV, #FSLR, #GOOGL, #LLY, #MA, #META, #MSFT, #NOW, #NXPI, #PYPL, #ROKU, #SBUX, #SOFI, #UNH, #UPS, #V, #VZ

Biogen Licenses Oral C5aR1 Antagonist from Vanqua Bio to Expand Immunology Portfolio Biogen Inc. (Nasdaq: BIIB) and Vanqua Bio today announced a license agreement granting Biogen

#BIIB Biogen Licenses Oral C5aR1 Antagonist from Vanqua Bio to Expand Immunology Portfolio

www.stocktitan.net/news/BIIB/biogen-license...

🛠️ ¡Una herramienta para gobernarlos a todos!
Martillo, alicates, cuchillo y más 🔩
La multiherramienta BIIB 12 en 1 es el regalo perfecto para cualquier ocasión 🎁
Encuéntrala hoy en cazandogangas.es

#Multiherramienta #RegalosOriginales #Herramientas #Gadgets #Ofertas #Chollos #CazandoGangas #BIIB

LEQEMBI® IQLIK™(lecanemab-irmb) Subcutaneous Autoinjector Named to TIME's "Best Inventions of 2025" TOKYO and CAMBRIDGE, Mass., Oct. 13, 2025/ PRNewswire/-- Eisai Co., Ltd. and Biogen Inc. announced today that LEQEMBI ® IQLIK™, a subcutaneous autoinjector formulation of lecanemab, for the treatment of Alzheimer's disease has been selected by TIME as one of the "Best Inventions of 2025" in the Medical and Healthcare category. TIME's annual list of the Best Inventions...

#BIIB LEQEMBI® IQLIK™(lecanemab-irmb) Subcutaneous Autoinjector Named to TIME's "Best Inventions of 2025"

www.stocktitan.net/news/BIIB/leqembi-iqlikt...